Follow
JUST IN - Pfizer stock falls over 5% after halting the development of an "experimental" obesity drug over safety concerns.
Yaknow obesity would probably be less of an issue if we regulated what food monopolies actually put into their products.
On top of that if we had a healthcare system that was actually able to help patients instead of just treat them, then we might actually get the obesity rate under control.
Stock